SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-034148
Filing Date
2024-08-28
Accepted
2024-08-28 12:54:22
Documents
14
Period of Report
2024-08-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45750
  Complete submission text file 0001493152-24-034148.txt   269550

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cing-20240828.xsd EX-101.SCH 3781
3 XBRL DEFINITION FILE cing-20240828_def.xml EX-101.DEF 30042
4 XBRL LABEL FILE cing-20240828_lab.xml EX-101.LAB 36718
5 XBRL PRESENTATION FILE cing-20240828_pre.xml EX-101.PRE 27065
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5714
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 241253646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)